Simplex Trading, LLC Exagen Inc. Transaction History

Simplex Trading, LLC

  • $3.35 Billion
  • Q1 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

Apr 27, 2023
SELL
$2.23 - $2.9 $695 - $904
-312 Reduced 57.04%
235 $0
Q4 2022

Feb 02, 2023
BUY
$2.1 - $3.4 $1,148 - $1,859
547 New
547 $1,000
Q1 2022

May 02, 2022
SELL
$7.12 - $11.06 $85 - $132
-12 Closed
0 $0
Q4 2021

Feb 23, 2022
BUY
$8.97 - $14.08 $107 - $168
12 New
12 $0

Others Institutions Holding XGN

# of Institutions
35
Shares Held
6.21M
Call Options Held
1.6K
Put Options Held
4.1K
View Full List

About EXAGEN INC.

XGN Quotes by TradingView
  • Ticker XGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 16,260,400
  • Market Cap $28.9M
  • Description
  • Exagen Inc. develops and commercializes various testing products based on its cell-bound complement activation products technology under the AVISE brand in the United States. It enables rheumatologists to care for patients through the diagnosis, prognosis, and monitoring of autoimmune and autoimmune-related diseases, including systemic lupus ery...
More about XGN
Track This Portfolio

Track Simplex Trading, LLC Portfolio

Follow Simplex Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Simplex Trading, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email